ZIM
ARRY

Zacks Investment Management’s Array Biopharma Inc ARRY Stock Holding History

Zacks Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-18,505
Closed -$165K – 736
2017
Q1 		$165K Buy
+18,505
New +$197K ﹤0.01% 606
2016
Q2 		– Sell
-38,181
Closed -$113K – 743
2016
Q1 		$113K Buy
+38,181
New +$114K ﹤0.01% 586
2015
Q1 		– Sell
-51,187
Closed -$242K – 749
2014
Q4 		$242K Buy
+51,187
New +$202K 0.01% 559

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Zacks Investment Management's ARRY Position: Q2 2017 in Review

Zacks Investment Management sold out of Array Biopharma Inc (ARRY) in Q2 2017, closing a stake of 18,505 shares — an estimated $165K sold.

Zacks Investment Management first reported a position in ARRY in Q4 2014 and held it in 3 quarters. The position peaked at $242K in Q4 2014. 182 funds tracked by Wall St. Rank hold ARRY as of Q2 2017.

  • Zacks Investment Management reported no remaining Array Biopharma Inc position as of Q2 2017 after selling out during the quarter.
  • Zacks Investment Management sold 18,505 Array Biopharma Inc shares in Q2 2017, an estimated $165K.
  • Zacks Investment Management first reported a position in Array Biopharma Inc in Q4 2014 and held it in 3 quarters.
  • Zacks Investment Management's Array Biopharma Inc position peaked at $242K in Q4 2014.
  • 182 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2017.

Based on Zacks Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.